德鲁帕辛作为一种强大的SARS-CoV-2复制抑制剂体外
Chen Yang1, Yanying Yu1, Qi Peng2
1School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
Biosafety and health
|March 13, 2025
概括
研究人员确定了一种天然化合物德鲁帕辛,作为一种有前途的抗病毒剂,可以对抗严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2). 德鲁帕辛通过一种新的机制抑制病毒复制,为COVID-19提供了一个新的治疗支架.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 传染性疾病 传染性疾病
背景情况:
- 新出现的SARS-CoV-2变种需要超越疫苗和现有治疗方法的新型抗病毒疗法.
- 之前开发的SARS-CoV-2转录和复制能力强的病毒样粒子 (trVLP) 系统模拟了完整的病毒生命周期.
- 高含量查 (HCS) 与细胞培养系统相结合,为大规模的抗病毒化合物评估提供了可靠的方法.
研究的目的:
- 用面向表型的查方法识别针对SARS-CoV-2的新型抗病毒化合物.
- 评估已识别的化合物在抑制病毒复制和转录方面的疗效.
- 为了研究潜在的抗病毒候选者的作用机制.
主要方法:
- 使用SARS-CoV-2trVLP细胞培养系统进行高含量查.
- 选了3,200种天然化合物的库,以检测抗病毒活性.
- 采用SARS-CoV-2复制系统来确认病毒基因组转录和复制的抑制.
- 进行了酶定量测试以评估关键病毒蛋白 (nsp5和nsp12) 的抑制.
主要成果:
- 从自然化合物库中,drupacine被确定为SARS-CoV-2感染的强有力的抑制剂.
- 德鲁帕辛证明了病毒基因组转录和复制在复制系统中的抑制.
- 酶分析表明,德鲁帕辛的机制不涉及直接抑制nsp5 (MPro) 或nsp12 (RdRp).
结论:
- 德鲁帕辛是一种有希望的抗病毒候选人,可以对抗SARS-CoV-2,与传统的标不同.
- 这些发现表明德鲁帕辛是开发新的抗COVID-19治疗方法的新型支架.
- 需要进一步的研究来阐明德鲁帕辛的精确分子标和作用机制.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.6K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
161
相关概念视频
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
